Exosomal miRNA-92a derived from cancer-associated fibroblasts promote invasion and metastasis in breast cancer by regulating G3BP2
Cellular Signalling · 2024-07 · 119 · 111182
DOI: 10.1016/j.cellsig.2024.111182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2024-07. Verfasst von Zhimei Sheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, China; Department of Pathology, Aff…. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer-Associated Fibroblasts, Cell Movement, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shandong Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer-associated Fibroblasts (CAFs) exert a tumor-promoting effect in various cancers, including breast cancer. CAFs secrete exosomes containing miRNA and proteins, influencing the tumor microenvironment. In this study, we identified CAF-derived exosomes that transport functional miR-92a from CAFs to tumor cells, thereby intensifying the aggressiveness of breast cancer. CAFs downregulate the expression of G3BP2 in breast cancer cells, and a significant elevation in miR-92a levels in CAF-derived exosomes was observed. Both in vitro and in vivo experiments demonstrate that miR-92a enhances breast cancer cell migration and invasion by directly targeting G3BP2, functioning as a tumor-promoting miRNA. We validated that the RNA-binding proteins SNRPA facilitate the transfer of CAF-derived exosomal miR-92a to breast cancer cells. The reduction of G3BP2 protein by CAF-derived exosomes releases TWIST1 into the nucleus, promoting epithelial-mesenchymal transition (EMT) and further exacerbating breast cancer progression. Moreover, CAF-derived exosomal miR-92a induces tumor invasion and metastasis in mice. Overall, our study reveals that CAF-derived exosomal miR-92a serves as a promoter in the migration and invasion of breast cancer cells by reducing G3BP2 and may represent a potential novel tumor marker for breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, China; Department of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang, Shand…
- Department of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, China.
- Department of Pathology, Weifang people's Hospital, Weifang, Shandong, China.
- Department of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.
- Department of Physiology, Second Medical University, Weifang, Shandong, China.
Förderung
- Shandong Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Sheng, Z., Wang, X., Ding, X., Zheng, Y., Guo, A., Cui, J., Ma, J., Duan, W., Dong, H., Zhang, H., Cui, M., Su, W., & Zhang, B. (2024). Exosomal miRNA-92a derived from cancer-associated fibroblasts promote invasion and metastasis in breast cancer by regulating G3BP2. Cellular Signalling, 119, 111182. https://doi.org/10.1016/j.cellsig.2024.111182
Vancouver
Sheng Z, Wang X, Ding X, Zheng Y, Guo A, Cui J, et al. Exosomal miRNA-92a derived from cancer-associated fibroblasts promote invasion and metastasis in breast cancer by regulating G3BP2. Cellular Signalling. 2024;119:111182. doi:10.1016/j.cellsig.2024.111182
BibTeX
@article{Sheng2024,
author = {Sheng, Zhimei and Wang, Xuejie and Ding, Xiaodi and Zheng, Yuanhang and Guo, Ai and Cui, Jiayu and Ma, Jing and Duan, Wanli and Dong, Hao and Zhang, Hongxing and Cui, Meimei and Su, Wenxia and Zhang, Baogang},
title = {Exosomal miRNA-92a derived from cancer-associated fibroblasts promote invasion and metastasis in breast cancer by regulating G3BP2},
journal = {Cellular Signalling},
year = {2024},
volume = {119},
pages = {111182},
doi = {10.1016/j.cellsig.2024.111182}
}
EUVIMED